IVBXF News and Press, Innovent Biologics Inc

2026-03-26 07:39:09 ET More on Innovent Biologics Eli Lilly expands partnership with Innovent to develop oncology, immunology drugs Historical earnings data for Innovent Biologics Financial information for Innovent Biologics Read the full article on Seeking...

2026-03-06 06:05:00 ET Listen below or on the go via Apple Podcasts and Spotify U.S. issues 30 day waiver (1:00) and considers requiring permits for global AI chip sales (2:45) China approves Pfizer’s GLP-1 (4:00)... Read the full article on Seeking Alph...

2026-02-08 10:33:49 ET More on Eli Lilly, Innovent Biologics Eli Lilly: Positives Outweigh The Concerns Eli Lilly and Company 2025 Q4 - Results - Earnings Call Presentation Eli Lilly and Company (LLY) Q4 2025 Earnings Call Transcript President Trump unveils T...

2026-01-05 09:53:52 ET On November 25, my first coverage of Novo Nordisk A/S ( NVO ) was published on Seeking Alpha. Responding to recent news that its long-shot potential Alzheimer’s indication for Wegovy did not materialize as hoped, I nevertheless initiated coverag...

2026-01-04 09:05:29 ET More on The Health Care Select Sector SPDR® Fund ETF Where To Find Outperformance In 2026 My S&P 500 Prediction On Sector Outperformers And Laggards In 2026 XLV: The Simple Case For Overweighting U.S. Health Care Notable health...

2025-12-30 07:43:40 ET More on Eli Lilly, Novo Nordisk Novo Nordisk: The Real Comeback Starts Now With The Wegovy Pill Eli Lilly: Mr. Market Finally Woke Up, But I'm Not Out Yet (Rating Downgrade) Eli Lilly: Short-Term Upside Exhausted (Rating Downgrade) CMS ...

2025-10-22 01:55:39 ET More on Innovent Biologics, Takeda Pharmaceutical Takeda: Excellent Pipeline Kaizen - 6 Drugs, $20 Billion Annually Takeda Pharmaceutical Company Limited (TAK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript Taked...

2025-08-27 06:28:01 ET More on Innovent Biologics Neutral On Innovent Biologics: Hard To Justify Its Premium How mazdutide compares against weight loss therapies from Novo Nordisk, Lilly Novo Nordisk, Eli Lilly face first major obesity drug rival in China as Innovent...

2025-08-27 06:27:08 ET More on Innovent Biologics Neutral On Innovent Biologics: Hard To Justify Its Premium How mazdutide compares against weight loss therapies from Novo Nordisk, Lilly Novo Nordisk, Eli Lilly face first major obesity drug rival in China as Innovent...

2025-07-30 09:00:00 ET Introduction The market was shaken yesterday by the news of a Novo Nordisk A/S ( NVO ) 20% drop in a single day. A 1-year decline is getting close to 60%, and it sounds disproportionate, especially when reminded we are talking about the company tha...